[Effect of azathioprine and inosiplex on rosette formation by lymphocytes from normal donors and from patients with neoplasia (author's transl)]. 1981

C De Simone, and C Capozzi, and S Campo, and D Ricca, and G Matteucci

The effect of azathioprine and inosiplex on the capacity of peripheral blood lymphocytes to form E active rosettes has been studied in vitro on 25 healthy subjects and 63 cancer patients (27 with pulmonary cancer and 36 with cancer of the digestive tract). Azathioprine significantly inhibited the capacity of T cells obtained from normal donors to form rosettes (P less than 0.01). Similar results were registered in patients suffering from pulmonary cancer (P less than 0.01) or from digestive neoplasia (P less than 0.05). Inosiplex, a substance with antiviral and immunomodulating properties, increased the percentage of the E active rosettes forming cells of 18 subjects with lung carcinoma and 26 patients with cancer of the gastrointestinal apparatus. If lymphocytes of both normal donors and cancer patients were preincubated simultaneously with azathioprine and inosiplex, the latter had an inhibitory effect on the azathioprine dependent rosette inhibition and restored the percentage of the E active rosette forming cells to control values.

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D007288 Inosine A purine nucleoside that has hypoxanthine linked by the N9 nitrogen to the C1 carbon of ribose. It is an intermediate in the degradation of purines and purine nucleosides to uric acid and in pathways of purine salvage. It also occurs in the anticodon of certain transfer RNA molecules. (Dorland, 28th ed)
D007542 Inosine Pranobex An alkylamino-alcohol complex of inosine used in the treatment of a variety of viral infections. Unlike other antiviral agents, it acts by modifying or stimulating cell-mediated immune processes rather than acting on the virus directly. Inosiplex,Methisoprinol,Imunovir,Isoprinosin,Isoprinosine,Methysoprinol,Metisoprinol,NPT-10381,NPT 10381,NPT10381,Pranobex, Inosine
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D005260 Female Females
D005770 Gastrointestinal Neoplasms Tumors or cancer of the GASTROINTESTINAL TRACT, from the MOUTH to the ANAL CANAL. Gastrointestinal Cancer,Cancer of Gastrointestinal Tract,Cancer of the Gastrointestinal Tract,Neoplasms, Gastrointestinal,Cancer, Gastrointestinal,Cancers, Gastrointestinal,Gastrointestinal Cancers,Gastrointestinal Neoplasm,Gastrointestinal Tract Cancer,Gastrointestinal Tract Cancers,Neoplasm, Gastrointestinal

Related Publications

C De Simone, and C Capozzi, and S Campo, and D Ricca, and G Matteucci
June 1979, Zeitschrift fur Immunitatsforschung. Immunobiology,
C De Simone, and C Capozzi, and S Campo, and D Ricca, and G Matteucci
March 1980, Zhonghua nei ke za zhi,
C De Simone, and C Capozzi, and S Campo, and D Ricca, and G Matteucci
November 1974, Annales d'immunologie,
C De Simone, and C Capozzi, and S Campo, and D Ricca, and G Matteucci
April 1977, Nihon Hifuka Gakkai zasshi. The Japanese journal of dermatology,
C De Simone, and C Capozzi, and S Campo, and D Ricca, and G Matteucci
July 1977, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
C De Simone, and C Capozzi, and S Campo, and D Ricca, and G Matteucci
January 1973, Bollettino dell'Istituto sieroterapico milanese,
C De Simone, and C Capozzi, and S Campo, and D Ricca, and G Matteucci
December 1981, Israel journal of medical sciences,
C De Simone, and C Capozzi, and S Campo, and D Ricca, and G Matteucci
January 1977, Zentralblatt fur Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene. Erste Abteilung Originale. Reihe A: Medizinische Mikrobiologie und Parasitologie,
C De Simone, and C Capozzi, and S Campo, and D Ricca, and G Matteucci
August 1977, Clinical and experimental immunology,
C De Simone, and C Capozzi, and S Campo, and D Ricca, and G Matteucci
January 1980, Kekkaku : [Tuberculosis],
Copied contents to your clipboard!